Velpanat tablets supplier USA
Velpanat is a fixed-dose combination antiviral medication used for the treatment of chronic Hepatitis C virus (HCV) infection, covering all six major genotypes (1-6). Each tablet contains Sofosbuvir 400 mg and Velpatasvir 100 mg, making it a convenient, once-daily oral treatment that offers a high cure rate across diverse patient populations.
Velpanat is a breakthrough, pangenotypic, direct-acting antiviral (DAA) medication developed by Natco Pharma for the treatment of chronic Hepatitis C infection in adults. It contains two potent antiviral agents:
Together, these drugs work synergistically to stop the hepatitis C virus from replicating and spreading in the body. Velpanat is especially effective because it can treat all genotypes of HCV (1 through 6), reducing the need for genotype-specific regimens.
Velpanat is typically administered once daily for 12 weeks, with or without Ribavirin based on the patient’s liver condition (e.g., decompensated cirrhosis).
Key Features:
Contains Sofosbuvir 400 mg + Velpatasvir 100 mg
Pangenotypic – treats genotypes 1 to 6 of HCV
High cure rates (SVR >95%) after a 12-week treatment course
No need for interferon or multiple pills
Manufactured by Natco Pharma Ltd, a trusted name in Hepatitis C treatment
WHO-prequalified and widely used in global treatment programs
Indications:
Chronic Hepatitis C infection (genotypes 1–6)
With or without compensated or decompensated cirrhosis
Suitable for treatment-naïve or treatment-experienced adults
Dosage and Administration:
Standard dose: One tablet once daily, with or without food
Treatment duration: Typically 12 weeks; may be 24 weeks in patients with decompensated cirrhosis (often with Ribavirin)
Follow your doctor’s complete instructions for optimal results
Precautions:
Not recommended during pregnancy (especially if combined with Ribavirin)
Use with caution in patients with severe liver or kidney disease
May interact with other medications, especially antacids, anticonvulsants, and HIV drugs
Inform your doctor of any pre-existing conditions, including co-infection with HIV or Hepatitis B
Storage Instructions:
Store at room temperature below 30°C
Keep away from moisture, heat, and direct sunlight
Keep out of reach of children
